China’s CanSino single-dose COVID-19 vaccine co-developed by Beijing’s top military bio-warfare expert ‘shows 65.7 per cent efficacy’

The vaccine developed by Chinese firm CanSinoBIO and a team led by Chen Wei, Beijing’s top military bio-warfare expert, is reported to show 65.7 per cent efficacy in preventing symptomatic cases.
( read original story …)